Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement

American Journal of Respiratory and Critical Care Medicine

Volumn 200, Issue 8, 2019, Pages E70-E88

  Graham, Brian L ^a   Steenbruggen, Irene ^b   Barjaktarevic, Igor Z ^c   Cooper, Brendan G ^d,e   Hall, Graham L ^f,g   Hallstrand, Teal S ^h   Kaminsky, David A ⁱ   McCarthy, Kevin ^j   McCormack, Meredith C ^k   Miller, Martin R ^l   Oropez, Cristine E ^m   Rosenfeld, Margaret ^h   Stanojevic, Sanja ⁿ   Swanney, Maureen P ^o   Thompson, Bruce R ^p  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ISALA HOSPITAL   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f PERTH CHILDREN S HOSPITAL   (Australia)

^g CURTIN UNIVERSITY   (Australia)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^j ERT Inc   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^m UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

ⁿ HOSPITAL FOR SICK CHILDREN   (Canada)

^o CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^p SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

more..

Author keywords

Pulmonary function; Spirometer; Spirometry; Technical standards

Indexed keywords

BRONCHODILATING AGENT;

CONSENSUS DEVELOPMENT; EUROPE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GOOD LABORATORY PRACTICE; HUMAN; HYGIENE; INFECTION CONTROL; LABORATORY TEST; LUNG FUNCTION TEST; MEDICAL SOCIETY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SPIROMETRY; STANDARDIZATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNITED STATES; VITAL CAPACITY; ADVISORY COMMITTEE; LUNG DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE;

ADVISORY COMMITTEES; EUROPE; HUMANS; LUNG DISEASES; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY FUNCTION TESTS; SOCIETIES, MEDICAL; SPIROMETRY; UNITED STATES;

EID: 85073178954     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201908-1590ST     Document Type: Review

References (147)

1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
2. American Thoracic Society. ATS statement: snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979;119:831-838.
3. Statement of the American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987;136:1285-1298.
4. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
5. Quanjer PH. Standardized lung function testing: report working party standardization of lung function tests. Bull Eur Physiopathol Respir 1983;19(Suppl 5):1-95.
6. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6(Suppl 16):5-40.
7. Redlich CA, Tarlo SM, Hankinson JL, Townsend MC, Eschenbacher WL, Von Essen SG, et al.; American Thoracic Society Committee on Spirometry in the Occupational Setting. Official American Thoracic Society technical standards: spirometry in the occupational setting. Am J Respir Crit Care Med 2014;189:983-993.
8. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, et al.; American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007;175:1304-1345.
9. Graham BL. Pulmonary function standards: a work in progress. Respir Care 2012;57:1199-1200.
10. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al.; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005;26:153-161.
11. Hegewald MJ, Gallo HM, Wilson EL. Accuracy and quality of spirometry in primary care offices. Ann Am Thorac Soc 2016;13:2119-2124.
12. Schermer TRJ, Verweij EHA, Cretier R, Pellegrino A, Crockett AJ, Poels PJ. Accuracy and precision of desktop spirometers in general practices. Respiration 2012;83:344-352.
13. Bambra G, Jalota L, Kapoor C, Mills PK, Vempilly JJ, Jain VV. Office spirometry correlates with laboratory spirometry in patients with symptomatic asthma and COPD. Clin Respir J 2017;11:805-811.
14. Licskai CJ, Sands TW, Paolatto L, Nicoletti I, Ferrone M. Spirometry in primary care: an analysis of spirometery test quality in a regional primary care asthma program. Can Respir J 2012;19: 249-254.
15. Epton MJ, Stanton JD, McGeoch GR, Shand BI, Swanney MP. The development of a community-based spirometry service in the Canterbury region of New Zealand: observations on new service delivery. NPJ Prim Care Respir Med 2015;25:15003.
16. Cooper BG. An update on contraindications for lung function testing. Thorax 2011;66:714-723.
17. Coates AL, Graham BL, McFadden RG, McParland C, Moosa D, Provencher S, et al.; Canadian Thoracic Society. Spirometry in primary care. Can Respir J 2013;20:13-21.
18. Vieira GM, Oliveira HB, de Andrade DT, Bottaro M, Ritch R. Intraocular pressure variation during weight lifting. Arch Ophthalmol 2006;124: 1251-1254.
19. Tiller NB, Simpson AJ. Effect of spirometry on intra-thoracic pressures. BMC Res Notes 2018;11:110.
20. Boerrigter BG, Bogaard HJ, Vonk-Noordegraaf A. Spirometry in chronic obstructive pulmonary disease: a hemodynamic roller coaster? Am J Respir Crit Care Med 2012;186:e6-e7.
21. Roberts C, Ward S, Walsted E, Hull JH. Safety of pulmonary function testing: data from 20 years. Thorax 2018;73:385-387.
22. García-Río F, Calle M, Burgos F, Casan P, Del Campo F, Galdiz JB, et al.; Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Spirometry. Arch Bronconeumol 2013;49:388-401.
23. Araújo CG, Vianna LC. How often does spirometry testing induce cardiac arrhythmias? Prim Care Respir J 2009;18:185-188.
24. Zagami D, Wilson J, Bodger A, Sriram KB. Respiratory function testing is safe in patients with abdominal aortic aneurysms. Vasc Endovascular Surg 2014;48:522-523.
25. Goodyear SJ, Yow H, Saedon M, Shakespeare J, Hill CE, Watson D, et al. Risk stratification by pre-operative cardiopulmonary exercise testing improves outcomes following elective abdominal aortic aneurysm surgery: a cohort study. Perioper Med (Lond) 2013;2:10.
26. Frost F, Peat R, McWean J, Shaw M, Field M, Nazareth D, et al. Pulmonary function testing is safe in patients with thoracic aortic aneurysms. Eur Respir J 2018;52:1800928.
27. Johns DP, Hartley MF, Burns G, Thompson BR. Variation in barometric pressure in Melbourne does not significantly affect the BTPS correction factor. Respirology 2004;9:406-408.
28. Lalloo UG, Becklake MR, Goldsmith CM. Effect of standing versus sitting position on spirometric indices in healthy subjects. Respiration 1991;58:122-125.
29. Gudmundsson G, Cerveny M, Shasby DM. Spirometric values in obese individuals: effects of body position. Am J Respir Crit Care Med 1997;156:998-999.
30. Swamy K, Isroff C, Mhanna MJ, Chouksey AK. Effect of sitting vs standing posture on spirometry in children. Ann Allergy Asthma Immunol 2016;117:94-96.
31. Pal AK, Tiwari S, Verma DK. Effect of recumbent body positions on dynamic lung function parameters in healthy young subjects. J Clin Diagn Res 2017;11:CC08-CC10.
32. Katz S, Arish N, Rokach A, Zaltzman Y, Marcus EL. The effect of body position on pulmonary function: a systematic review. BMC Pulm Med 2018;18:159.
33. Kendrick AH, Johns DP, Leeming JP. Infection control of lung function equipment: a practical approach. Respir Med 2003;97:1163-1179.
34. Rasam SA, Apte KK, Salvi SS. Infection control in the pulmonary function test laboratory. Lung India 2015;32:359-366.
35. Pittet D, Allegranzi B, Boyce J; World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts. The World Health Organization guidelines on hand hygiene in health care and their consensus recommendations. Infect Control Hosp Epidemiol 2009;30:611-622.
36. Saiman L, Siegel JD, LiPuma JJ, Brown RF, Bryson EA, Chambers MJ, et al.; Cystic Fibrous Foundation; Society for Healthcare Epidemiology of America. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014; 35(Suppl 1):S1-S67.
37. Wanger J, Mottram C. ATS pulmonary function laboratory management and procedure manual, 3rd ed. New York: American Thoracic Society; 2016.
38. International Organization for Standardization. ISO 26782. Anaesthetic and respiratory equipment: spirometers intended for the measurement of time forced expired volumes in humans. Geneva, Switzerland: International Organization for Standardization; 2016.
39. McCormack MC, Shade D, Wise RA. Spirometer calibration checks: is 3.5% good enough? Chest 2007;131:1486-1493.
40. Lefebvre Q, Vandergoten T, Derom E, Marchandise E, Liistro G. Testing spirometers: are the standard curves of the American Thoracic Society sufficient? Respir Care 2014;59:1895-1904.
41. Miller MR, Lloyd J, Bright P. Recording flow in the first second of a maximal forced expiratory manoeuvre: influence of frequency content. Eur Respir J 2002;19:530-533.
42. Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017;49:1600016.
43. Miller MR, Sigsgaard T. Prevention of thermal and condensation errors in pneumotachographic recordings of the maximal forced expiratory manoeuvre. Eur Respir J 1994;7:198-201.
44. Johnson LR, Enright PL, Voelker HT, Tashkin DP. Volume spirometers need automated internal temperature sensors. Am J Respir Crit Care Med 1994;150:1575-1580.
45. Haynes JM, Ruppel GL. Should spirometer quality control be treated like other laboratory devices? ERJ Open Res 2019;5:00249-2018.
46. Westgard JO, Groth T, Aronsson T, Falk H, de Verdier CH. Performance characteristics of rules for internal quality control: probabilities for false rejection and error detection. Clin Chem 1977;23: 1857-1867.
47. Madsen F. Validation of spirometer calibration syringes. Scand J Clin Lab Invest 2012;72:608-613.
48. Ruppel GL, Enright PL. Pulmonary function testing. Respir Care 2012; 57:165-175.
49. Cooper BG, Steenbruggen I, Mitchell S, Severin T, Oostveen E, Burgos F, et al. HERMES spirometry: the European Spirometry Driving Licence. Breathe (Sheff) 2011;7:258-275.
50. Steenbruggen I, Mitchell S, Severin T, Palange P, Cooper BG; Spirometry HERMES Task Force. Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe. Eur Respir J 2011;37: 479-481.
51. Swanney MP, O'Dea CA, Ingram ER, Rodwell LT, Borg BM; ANZSRS Spirometry Training Course Working Group. Spirometry training courses: content, delivery and assessment: a position statement from the Australian and New Zealand Society of Respiratory Science. Respirology 2017;22:1430-1435.
52. Borg BM, Hartley MF, Fisher MT, Thompson BR. Spirometry training does not guarantee valid results. Respir Care 2010;55:689-694.
53. Represas-Represas C, Botana-Rial M, Leiro-Fernández V, González-Silva AI, García-Martínez A, Fernández-Villar A. Short- and long-term effectiveness of a supervised training program in spirometry use for primary care professionals. Arch Bronconeumol 2013;49: 378-382.
54. Haynes JM. Quality assurance of the pulmonary function technologist. Respir Care 2012;57:114-122. [Discussion, pp. 122-126.]
55. Quanjer PH, Hall GL, Stanojevic S, Cole TJ, Stocks J; Global Lungs Initiative. Age- and height-based prediction bias in spirometry reference equations. Eur Respir J 2012;40:190-197.
56. Gauld LM, Kappers J, Carlin JB, Robertson CF. Height prediction from ulna length. Dev Med Child Neurol 2004;46:475-480.
57. Quanjer PH, Capderou A, Mazicioglu MM, Aggarwal AN, Banik SD, Popovic S, et al. All-age relationship between arm span and height in different ethnic groups. Eur Respir J 2014;44:905-912.
58. Braun L, Wolfgang M, Dickersin K. Defining race/ethnicity and explaining difference in research studies on lung function. Eur Respir J 2013;41:1362-1370.
59. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the Global Lung Function 2012 equations. Eur Respir J 2012;40:1324-1343.
60. Bucca CB, Carossa S, Colagrande P, Brussino L, Chiavassa G, Pera P, et al. Effect of edentulism on spirometric tests. Am J Respir Crit Care Med 2001;163:1018-1020.
61. Indrakumar HS, Venkatesh D, Adoni VV, Kashyap R, Jayanthi D, Prakash N. Spirometric assessment of impact of complete dentures on respiratory performance: an in vitro study. J Contemp Dent Pract 2018;19:177-180.
62. Banerjee SK, Davies M, Sharples L, Smith I. The role of facemask spirometry in motor neuron disease. Thorax 2013;68:385-386.
63. Wanger JS, Ikle DN, Cherniack RM. The effect of inspiratory maneuvers on expiratory flow rates in health and asthma: influence of lung elastic recoil. Am J Respir Crit Care Med 1996;153:1302-1308.
64. D'Angelo E, Prandi E, Milic-Emili J. Dependence of maximal flow-volume curves on time course of preceding inspiration. J Appl Physiol (1985) 1993;75:1155-1159.
65. Stoller JK, Basheda S, Laskowski D, Goormastic M, McCarthy K. Trial of standard versus modified expiration to achieve end-of-test spirometry criteria. Am Rev Respir Dis 1993;148:275-280.
66. Stoller JK, McCarthy K. Benefits of a modified spirometry technique. Eur Respir J 2007;30:813-814, author reply 814-815.
67. Haynes JM, Kaminsky DA. The American Thoracic Society/European Respiratory Society acceptability criteria for spirometry: asking too much or not enough? Respir Care 2015;60:e113-e114.
68. Kozlowska WJ, Aurora P. Spirometry in the pre-school age group. Paediatr Respir Rev 2005;6:267-272.
69. Seed L, Wilson D, Coates AL. Children should not be treated like little adults in the PFT lab. Respir Care 2012;57:61-70. [Discussion, pp. 71-74.]
70. American Thoracic Society; European Respiratory Society. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med 2005;172: 1463-1471.
71. Newall C, McCauley TM, Shakespeare J, Cooper BG. Is it necessary to use a noseclip in the performance of spirometry using a wedge bellows device? Chron Respir Dis 2007;4:53-57.
72. McKibben JM, McKay RT, Freeman AG, Levin LS, Pinney SM, Alshaikh E. Redefining spirometry hesitating start criteria based on the ratio of extrapolated volume to timed FEVs. Chest 2011;140:164-169.
73. Müller-Brandes C, Krämer U, Gappa M, Seitner-Sorge G, Hüls A, von Berg A, et al. LUNOKID: can numerical American Thoracic Society/European Respiratory Society quality criteria replace visual inspection of spirometry? Eur Respir J 2014;43:1347-1356.
74. National Institute for Occupational Safety and Health (NIOSH). Spirometry quality assurance: common errors and their impact on test results. Washington, DC: NIOSH; 2012 [accessed 2019 May 5] DHHS (NIOSH) Publication No. 2012-116. Available from: https://www.cdc.gov/niosh/docs/2012-116/pdfs/2012-116.pdf.
75. Miller MR, Pedersen OF, Quanjer PH. The rise and dwell time for peak expiratory flow in patients with and without airflow limitation. Am J Respir Crit Care Med 1998;158:23-27.
76. Glover R, Cooper BG, Lloyd J. Forced expiratory time (FET) as an indicator for airways obstruction. Eur Respir J 2014;44:1819.
77. Giner J, Plaza V, Rigau J, Solà J, Bolíbar I, Sanchis J. Spirometric standards and patient characteristics: an exploratory study of factors affecting fulfillment in routine clinical practice. Respir Care 2014;59: 1832-1837.
78. Sumphao-Ngern P, Foocharoen C, Boonsawat W, Mahakkanukrauh A, Suwannaroj S, Sae-Oue U, et al.; Scleroderma Research Group. Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis. Arch Med Sci 2015;11: 1255-1260.
79. Czajkowska-Malinowska M, Tomalak W, Radliński J. Quality of spirometry in the elderly. Pneumonol Alergol Pol 2013;81:511-517.
80. Hankinson JL, Eschenbacher B, Townsend M, Stocks J, Quanjer PH. Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test. Eur Respir J 2015; 45:1283-1292.
81. Torre-Bouscoulet L, Velázquez-Uncal M, García-Torrentera R, Gochicoa-Rangel L, Fernández-Plata R, Enright P, et al. Spirometry quality in adults with very severe lung function impairment. Respir Care 2015;60:740-743.
82. Enright P, Vollmer WM, Lamprecht B, Jensen R, Jithoo A, Tan W, et al. Quality of spirometry tests performed by 9893 adults in 14 countries: the BOLD Study. Respir Med 2011;105:1507-1515.
83. Tan WC, Bourbeau J, O'Donnell D, Aaron S, Maltais F, Marciniuk D, et al.; CanCOLD Collaborative Research Group. Quality assurance of spirometry in a population-based study-predictors of good outcome in spirometry testing. COPD 2014;11:143-151.
84. Janssens W, Liu Y, Liu D, Kesten S, Tashkin DP, Celli BR, et al. Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med 2013;107:1409-1416.
85. Tomalak W, Radliński J, Latawiec W. Quality of spirometric measurements in children younger than 10 years of age in the light of the recommendations [in Polish]. Pneumonol Alergol Pol 2008;76:421-425.
86. Hankinson JL, Bang KM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population. Am Rev Respir Dis 1991;143:516-521.
87. Kirkby J, Welsh L, Lum S, Fawke J, Rowell V, Thomas S, et al.; EPICure Study Group. The EPICure study: comparison of pediatric spirometry in community and laboratory settings. Pediatr Pulmonol 2008;43: 1233-1241.
88. Enright PL, Beck KC, Sherrill DL. Repeatability of spirometry in 18,000 adult patients. Am J Respir Crit Care Med 2004;169:235-238.
89. Gochicoa-Rangel L, Vargas-Domínguez C, García-Mujica ME, Bautista-Bernal A, Salas-Escamilla I, Pérez-Padilla R, et al. Quality of spirometry in 5-to-8-year-old children. Pediatr Pulmonol 2013;48: 1231-1236.
90. Ferris BG Jr, Speizer FE, Bishop Y, Prang G, Weener J. Spirometry for an epidemiologic study: deriving optimum summary statistics for each subject. Bull Eur Physiopathol Respir 1978;14:145-166.
91. Kanner RE, Schenker MB, Muñoz A, Speizer FE. Spirometry in children: methodology for obtaining optimal results for clinical and epidemiologic studies. Am Rev Respir Dis 1983;127: 720-724.
92. Barjaktarevic I, Kaner R, Buhr RG, Cooper CB. Bronchodilator responsiveness or reversibility in asthma and COPD: a need for clarity. Int J Chron Obstruct Pulmon Dis 2018;13:3511-3513.
93. Davis BE, Blais CM, Cockcroft DW. Methacholine challenge testing: comparative pharmacology. J Asthma Allergy 2018;11:89-99.
94. LaForce C, Korenblat P, Osborne P, Dong F, Higgins M. 24-Hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol. Curr Med Res Opin 2009;25:2353-2359.
95. Jones TE, Southcott A, Homan S. Drugs potentially affecting the extent of airways reversibility on pulmonary function testing are frequently consumed despite guidelines. Int J Chron Obstruct Pulmon Dis 2013; 8:383-388.
96. Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests: asthma outcome. Am J Respir Crit Care Med 1994;149:S9-S18. [Discussion, pp. S19-S20.]
97. Ward H, Cooper BG, Miller MR. Improved criterion for assessing lung function reversibility. Chest 2015;148:877-886.
98. 1 in severe airflow obstruction. Chest 2017; 151:1088-1098.
99. Crenesse D, Berlioz M, Bourrier T, Albertini M. Spirometry in children aged 3 to 5 years: reliability of forced expiratory maneuvers. Pediatr Pulmonol 2001;32:56-61.
100. Piccioni P, Borraccino A, Forneris MP, Migliore E, Carena C, Bignamini E, et al. Reference values of forced expiratory volumes and pulmonary flows in 3-6 year children: a cross-sectional study. Respir Res 2007;8:14.
101. Cockcroft DW, Berscheid BA. Volume adjustment of maximal midexpiratory flow: importance of changes in total lung capacity. Chest 1980;78:595-600.
102. 6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000;162:917-919.
103. 1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 2005;127:1560-1564.
104. 6 in the general population. Clin Physiol Funct Imaging 2008;28:196-201.
105. 6 in the elderly: correlates of performance and repeatability. Thorax 2008;63:60-66.
106. 1/FVC: the PLATINO longitudinal study. PLoS One 2013;8: e67960.
107. 6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J 2006;27:374-377.
108. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
109. 3/FVC to improve detection of airway obstruction. Chronic Obstr Pulm Dis 2015;2:94-102.
110. Marsh S, Aldington S, Williams M, Weatherall M, Shirtcliffe P, McNaughton A, et al. Complete reference ranges for pulmonary function tests from a single New Zealand population. N Z Med J 2006;119:U2281. [Published erratum appears in N Z Med J 120: U2551.]
111. Tian XY, Liu CH, Wang DX, Ji XL, Shi H, Zheng CY, et al. Spirometric reference equations for elderly Chinese in Jinan aged 60-84 Years. Chin Med J (Engl) 2018;131:1016-1022.
112. Raposo LB, Bugalho A, Gomes MJ. Contribution of flow-volume curves to the detection of central airway obstruction. J Bras Pneumol 2013;39:447-454.
113. Modrykamien AM, Gudavalli R, McCarthy K, Liu X, Stoller JK. Detection of upper airway obstruction with spirometry results and the flow-volume loop: a comparison of quantitative and visual inspection criteria. Respir Care 2009;54: 474-479.
114. Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, et al.; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories. Recommendations for a standardized pulmonary function report: an Official American Thoracic Society technical statement. Am J Respir Crit Care Med 2017;196: 1463-1472.
115. Salas T, Rubies C, Gallego C, Muñoz P, Burgos F, Escarrabill J. Technical requirements of spirometers in the strategy for guaranteeing the access to quality spirometry. Arch Bronconeumol 2011;47:466-469.
116. Goel A, Goyal M, Singh R, Verma N, Tiwari S. Diurnal variation in peak expiratory flow and forced expiratory volume. J Clin Diagn Res 2015;9:CC05-CC07.
117. Fregonezi G, Resqueti VR, Cury JL, Paulin E, Brunetto AF. Diurnal variations in the parameters of pulmonary function and respiratory muscle strength in patients with COPD. J Bras Pneumol 2012;38: 257-263.
118. Johnston R. PFT blog: a modest proposal for a clinical spirometry grading system. 2018 Sep 16 [accessed 2019 May 5]. Available from: https://www.pftforum.com/blog/a-modest-proposal-for-aclinical-spirometry-grading-system/#more-2420.
119. British Thoracic Society; Association of Respiratory Technology and Physiology. Guidelines for the measurement of respiratory function: British Thoracic Society and the Association of Respiratory Technology and Physiology. Respir Med 1994;88:165-194.
120. Babb TG, Viggiano R, Hurley B, Staats B, Rodarte JR. Effect of mild-to-moderate airflow limitation on exercise capacity. J Appl Physiol (1985) 1991;70:223-230.
121. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-549.
122. Pellegrino R, Rodarte JR, Brusasco V. Assessing the reversibility of airway obstruction. Chest 1998;114:1607-1612.
123. Younes M, Kivinen G. Respiratory mechanics and breathing pattern during and following maximal exercise. J Appl Physiol 1984;57: 1773-1782.
124. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-522.
125. Brusasco V, Pellegrino R, Rodarte JR. Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. Eur Respir J 1997;10:1316-1320.
126. Hansen LM, Pedersen OF, Lyager S, Naerra N. Differences in vital capacity due to the methods employed. Ugeskr Laeger 1983;145: 2752-2756.
127. Borg BM, Thompson BR. The measurement of lung volumes using body plethysmography: a comparison of methodologies. Respir Care 2012;57:1076-1083.
128. Russell AM, Adamali H, Molyneaux PL, Lukey PT, Marshall RP, Renzoni EA, et al. Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016;194:989-997.
129. Wang W, Finkelstein SM, Hertz MI. Automatic event detection in lung transplant recipients based on home monitoring of spirometry and symptoms. Telemed J E Health 2013;19:658-663.
130. Murgia F, Bianciardi F, Solvoll T, Tagliente I, Bella F, Carestia A, et al. Telemedicine home program in patients with cystic fibrosis: results after 10 years. Clin Ter 2015;166:e384-e388.
131. Burgos F, Disdier C, de Santamaria EL, Galdiz B, Roger N, Rivera ML, et al.; e-Spir@p Group. Telemedicine enhances quality of forced spirometry in primary care. Eur Respir J 2012;39: 1313-1318.
132. Marina Malanda N, López de Santa María E, Gutiérrez A, Bayón JC, Garcia L, Gáldiz JB. Telemedicine spirometry training and quality assurance program in primary care centers of a public health system. Telemed J E Health 2014;20:388-392.
133. Weiner DJ, Forno E, Sullivan L, Weiner GA, Kurland G. Subjective and objective assessments of flow-volume curve configuration in children and young adults. Ann Am Thorac Soc 2016;13: 1089-1095.
134. Dominelli PB, Foster GE, Guenette JA, Haverkamp HC, Eves ND, Dominelli GS, et al. Quantifying the shape of the maximal expiratory flow-volume curve in mild COPD. Respir Physiol Neurobiol 2015; 219:30-35.
135. Stuart-Andrews CR, Kelly VJ, Sands SA, Lewis AJ, Ellis MJ, Thompson BR. Automated detection of the phase III slope during inert gas washout testing. J Appl Physiol (1985) 2012;112: 1073-1081.
136. Anogeianaki A, Negrev N, Ilonidis G. Contributions of signal analysis to the interpretation of spirometry. Hippokratia 2007;11:187-195.
137. 8 at the start of spirometry may identify high-quality flow volume curves. Respirology 2017;22:527-532.
138. Melia U, Burgos F, Vallverdú M, Velickovski F, Lluch-Ariet M, Roca J, et al. Algorithm for automatic forced spirometry quality assessment: technological developments. PLoS One 2014;9:e116238.
139. Luo AZ, Whitmire E, Stout JW, Martenson D, Patel S. Automatic characterization of user errors in spirometry. Conf Proc IEEE Eng Med Biol Soc 2017;2017:4239-4242.
140. Velickovski F, Ceccaroni L, Marti R, Burgos F, Gistau C, Alsina-Restoy X, et al. Automated spirometry quality assurance: supervised learning from multiple experts. IEEE J Biomed Health Inform 2018; 22:276-284.
141. 3/FVC ratio is an indicator of mild lung injury. Chest 2013; 144:1117-1123.
142. 6 to diagnose airflow obstruction: comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc 2014;11:335-341.
143. Dilektasli AG, Porszasz J, Casaburi R, Stringer WW, Bhatt SP, Pak Y, et al.; COPDGene investigators. A novel spirometric measure identifies mild COPD unidentified by standard criteria. Chest 2016; 150:1080-1090.
144. 3: assessment of a surrogate spirometric parameter. Chest 2005;128:1274-1281.
145. Miller MR, Grove DM, Pincock AC. Time domain spirogram indices: their variability and reference values in nonsmokers. Am Rev Respir Dis 1985;132:1041-1048.
146. Liu C, Yang Y, Tsow F, Shao D, Tao N. Noncontact spirometry with a webcam. J Biomed Opt 2017;22:57002.
147. Coates AL, Wanger J, Cockcroft DW, Culver BH, Carlsen KH, Diamant Z, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J 2017;49:1601526.